NEKTAR THERAPEUTICS NKTR

US Healthcare Pharmaceutical Preparations
$71.04
+10.3%
52w: $8.51 – $100.35

Latest 13F among current holders filed 31 days ago (Jun 4, 2026)

Price — last 12 months

research preview data
8.5154.43100.35
Jun 20, 2025 Jul 2, 2026
Institutional holders
216
+35 QoQ
13F value
$1.92B
+161.9% QoQ
Smart-money holders
30
signal tier ≥ 2
New smart buyers
9
Q1 2026
Options barometer
1.9×
$68.4M calls / $35.5M puts

Institutional value by quarter

$105.8M
Q1 2024
$173.4M
Q2 2024
$184.1M
Q3 2024
$124.4M
Q4 2024
$84.4M
Q1 2025
$198.1M
Q2 2025
$820.6M
Q3 2025
$733.2M
Q4 2025
$1.92B
Q1 2026

Number of holders

124
Q1 2024
136
Q2 2024
141
Q3 2024
147
Q4 2024
158
Q1 2025
111
Q2 2025
154
Q3 2025
181
Q4 2025
216
Q1 2026

Who owns NKTR?

Q1 2026 filings
FundTypeSharesValue% of fundChange
FMR LLC Long only active4.3M$309.6M0.0%+4155.1%
BVF INC/IL ★3Fundamental concentrated2.6M$184.2M5.9%+64.1%
Two Seas Capital LP ★3Fundamental concentrated2.0M$141.0M6.5%+162.9%
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical1.2M$86.1M0.0%
TWO SIGMA INVESTMENTS, LP Quant stat arb930.7K$67.0M0.1%+96.8%
Prosight Management, LP ★2Fundamental concentrated735.0K$52.9M8.7%+32.5%
BlackRock, Inc. Index provider692.6K$49.8M0.0%+7.3%
MORGAN STANLEY Bank broker659.4K$47.4M0.0%+16.4%
ARMISTICE CAPITAL, LLC Quant stat arb578.0K$41.6M1.4%-3.0%
Invesco Ltd. Index provider567.5K$40.8M0.0%+21.2%
CITADEL ADVISORS LLC Multistrat pod513.5K$36.9M0.0%+65.8%
Sofinnova Investments, Inc. ★2Fundamental diversified509.5K$36.7M1.8%+16.2%
Woodline Partners LP Other415.3K$29.9M0.1%+299.4%
LORD, ABBETT & CO. LLC Other405.1K$29.1M0.1%New
MILLENNIUM MANAGEMENT LLC Multistrat pod404.3K$29.1M0.0%-11.0%
EMERALD ADVISERS, LLC Other394.6K$28.4M0.9%+2.7%
Qube Research & Technologies Ltd Quant stat arb390.7K$28.1M0.0%+20.6%
GEODE CAPITAL MANAGEMENT, LLC Index provider346.8K$25.0M0.0%+36.3%
UBS Group AG Bank broker320.2K$23.0M0.0%+11.3%
GREAT POINT PARTNERS LLC ★2Fundamental concentrated316.5K$22.8M5.6%+50.2%
Vestal Point Capital, LP ★2Fundamental diversified285.0K$20.5M0.6%New
22NW, LP ★3Fundamental concentrated281.1K$20.2M13.9%-15.1%
PRIMECAP MANAGEMENT CO/CA/ ★2Long only active279.1K$20.1M0.0%-0.4%
ORBIMED ADVISORS LLC ★2Fundamental diversified275.0K$19.8M0.4%New
GILDER GAGNON HOWE & CO LLC Other271.8K$19.6M0.2%+30.5%
Nearwater Capital Markets, Ltd Quant stat arb261.5K$18.8M0.4%+325.2%
EMERALD MUTUAL FUND ADVISERS TRUST Other256.1K$18.4M0.9%+1.2%
SUSQUEHANNA INTERNATIONAL GROUP, LLP Market maker249.1K$17.9M0.0%-35.0%
STATE STREET CORP Index provider244.7K$17.6M0.0%+25.1%
BRAIDWELL LP ★2Fundamental diversified222.7K$16.0M0.6%New
JPMORGAN CHASE & CO Bank broker240.1K$15.7M0.0%+59.2%
Patient Square Capital LP ★2Fundamental concentrated210.0K$15.1M2.7%New
Bronte Capital Management Pty Ltd. ★3Fundamental concentrated198.3K$14.3M1.5%New
Quinn Opportunity Partners LLC Other179.2K$12.9M0.7%+108.7%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical169.3K$12.2M0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Index provider168.0K$12.1M0.0%+39.6%
DAFNA Capital Management LLC ★2Fundamental diversified165.2K$11.9M2.7%+120.2%
ADAR1 Capital Management, LLC Other161.3K$11.6M0.7%+123.9%
MARSHALL WACE, LLP Quant stat arb140.6K$10.1M0.0%+485.2%
AMERIPRISE FINANCIAL INC Bank broker136.7K$9.8M0.0%New
GOLDMAN SACHS GROUP INC Bank broker126.9K$9.1M0.0%-14.1%
Creek Drive Management Group LLC ★2Fundamental concentrated126.4K$9.1M5.7%-31.9%
Squadron Capital Management LLC ★2Fundamental concentrated125.0K$9.0M3.6%New
SEVEN GRAND MANAGERS, LLC ★2Fundamental diversified125.0K$9.0M0.6%New
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. ★3Fundamental concentrated122.3K$8.8M0.7%-35.0%
BNP PARIBAS FINANCIAL MARKETS Bank broker121.5K$8.7M0.0%-42.2%
JANE STREET GROUP, LLC Market maker112.7K$8.1M0.0%-48.4%
Squarepoint Ops LLC Quant stat arb107.4K$7.7M0.0%+430.1%
Russell Investments Group, Ltd. Diversified mechanical106.2K$7.6M0.0%+24.0%
Tetragon Partners GP Ltd ★3Fundamental concentrated103.0K$7.4M1.5%+48.7%

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.